Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

2.41
BATS BZX Real-Time Price
As of 10:12am ET
 +0.06 / +2.55%
Today’s Change
0.68
Today|||52-Week Range
3.42
+205.37%
Year-to-Date
No recent news for DURECT Corp.

Today’s Trading

Previous close2.35
Today’s open2.30
Day’s range2.29 - 2.43
Volume73,124
Average volume (3 months)1,008,016
Market cap$297.7M
Dividend yield--
Data as of 9:56am ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)+4.76%
Earnings growth (this year)-25.00%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+26.59%
P/E ratioNM
Price/Sales4.54
Price/Book15.30

Competitors

 Today’s
change
Today’s
% change
SNTASynta Pharmaceutical...+0.01+0.47%
SYNSynthetic Biologics ...-0.01-0.31%
AGTCApplied Genetic Tech...+0.26+1.41%
SVASinovac Biotech Ltd+0.03+0.57%
Data as of 10:13am ET, 08/03/2015

Financials

Last reporting dateAugust 3, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$19.4M
Annual profit (last year)-$22.1M
Net profit margin-113.96%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Scientific Officer
Felix Theeuwes
President, Chief Executive Officer &
Director
James E. Brown
Corporate headquarters
Cupertino, California

Forecasts